<SEC-DOCUMENT>0001104659-25-043017.txt : 20250501
<SEC-HEADER>0001104659-25-043017.hdr.sgml : 20250501
<ACCEPTANCE-DATETIME>20250501070727
ACCESSION NUMBER:		0001104659-25-043017
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250501
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250501
DATE AS OF CHANGE:		20250501

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Armata Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0000921114
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				911549568
		STATE OF INCORPORATION:			WA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37544
		FILM NUMBER:		25899369

	BUSINESS ADDRESS:	
		STREET 1:		5005 MCCONNELL AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90066
		BUSINESS PHONE:		310-665-2928

	MAIL ADDRESS:	
		STREET 1:		5005 MCCONNELL AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90066

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AmpliPhi Biosciences Corp
		DATE OF NAME CHANGE:	20130222

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TARGETED GENETICS CORP /WA/
		DATE OF NAME CHANGE:	19940331
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2513778d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:armp="http://armatapharma.com/20250501">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_armp_armatapharma.com_20250501 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20250501_20250501 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0000921114 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-05-01" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-05-01" id="Fact000004" name="dei:EntityCentralIndexKey">0000921114</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="armp-20250501.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-05-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000921114</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-01</xbrli:startDate>
        <xbrli:endDate>2025-05-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 12pt"><b>UNITED STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 12pt"><b>SECURITIES AND
EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>Washington, DC
20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 12pt"><b>FORM <span id="xdx_906_edei--DocumentType_c20250501__20250501_zl1gqdKnLbmb"><ix:nonNumeric contextRef="AsOf2025-05-01" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 or 15(d) of
the<br/>
 Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of report (Date of earliest event reported):
<b><span id="xdx_90D_edei--DocumentPeriodEndDate_c20250501__20250501_zFFXR6EJqnS"><ix:nonNumeric contextRef="AsOf2025-05-01" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">May 1, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b><span id="xdx_90C_edei--EntityRegistrantName_c20250501__20250501_zccOugmMbCMd"><ix:nonNumeric contextRef="AsOf2025-05-01" id="Fact000011" name="dei:EntityRegistrantName">ARMATA PHARMACEUTICALS, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of Registrant as specified in
its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 33%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20250501__20250501_zsb7f758iPlk"><ix:nonNumeric contextRef="AsOf2025-05-01" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Washington</ix:nonNumeric></span></b></span></td>
    <td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="width: 33%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90D_edei--EntityFileNumber_c20250501__20250501_zNUaJnnZD2Y2"><ix:nonNumeric contextRef="AsOf2025-05-01" id="Fact000013" name="dei:EntityFileNumber">001-37544</ix:nonNumeric></span></b></span></td>
    <td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_900_edei--EntityTaxIdentificationNumber_c20250501__20250501_zUESLydHT3Wj"><ix:nonNumeric contextRef="AsOf2025-05-01" id="Fact000014" name="dei:EntityTaxIdentificationNumber">91-1549568</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(State or other jurisdiction <br/>
of incorporation or
    organization)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(IRS Employer Identification No.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 13%">&#160;</td>
<td style="text-align: center; width: 43%; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_90E_edei--EntityAddressAddressLine1_c20250501__20250501_zcS3NoIS2NRk"><b><ix:nonNumeric contextRef="AsOf2025-05-01" id="Fact000015" name="dei:EntityAddressAddressLine1">5005 McConnell Avenue</ix:nonNumeric></b></span><br/>
<b></b> <b><span id="xdx_903_edei--EntityAddressCityOrTown_c20250501__20250501_zdaIsXJDtSf8"><ix:nonNumeric contextRef="AsOf2025-05-01" id="Fact000016" name="dei:EntityAddressCityOrTown">Los Angeles</ix:nonNumeric></span></b><b>, <span id="xdx_909_edei--EntityAddressStateOrProvince_c20250501__20250501_zHGEzzOjBPNi"><ix:nonNumeric contextRef="AsOf2025-05-01" format="ixt-sec:stateprovnameen" id="Fact000017" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span></b></td>
    <td style="padding-bottom: 1pt; width: 1%">&#160;</td>
<td style="vertical-align: bottom; text-align: center; width: 44%; padding-right: 5.4pt; padding-left: 5.4pt"><b></b> <b><span id="xdx_905_edei--EntityAddressPostalZipCode_c20250501__20250501_zmvhW9Rvhiik"><ix:nonNumeric contextRef="AsOf2025-05-01" id="Fact000018" name="dei:EntityAddressPostalZipCode">90066</ix:nonNumeric></span></b></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><span style="font-size: 10pt">(Address of principal executive offices)</span></td>
    <td>&#160;</td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><span style="font-size: 10pt">(Zip Code)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_901_edei--CityAreaCode_c20250501__20250501_zLUuR3RblzT1"><ix:nonNumeric contextRef="AsOf2025-05-01" id="Fact000019" name="dei:CityAreaCode">310</ix:nonNumeric></span>) <span id="xdx_902_edei--LocalPhoneNumber_c20250501__20250501_zU2IsxVCJQP"><ix:nonNumeric contextRef="AsOf2025-05-01" id="Fact000020" name="dei:LocalPhoneNumber">655-2928</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s Telephone number)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_909_edei--WrittenCommunications_c20250501__20250501_zAt0RznS4iAl"><ix:nonNumeric contextRef="AsOf2025-05-01" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Wingdings"><span id="xdx_900_edei--SolicitingMaterial_c20250501__20250501_zJAVmNnKVXu4"><ix:nonNumeric contextRef="AsOf2025-05-01" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Wingdings"><span id="xdx_907_edei--PreCommencementTenderOffer_c20250501__20250501_zkefBEAo1vC"><ix:nonNumeric contextRef="AsOf2025-05-01" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Wingdings"><span id="xdx_909_edei--PreCommencementIssuerTenderOffer_c20250501__20250501_z5Fmqu8Ky6ib"><ix:nonNumeric contextRef="AsOf2025-05-01" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;
230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company&#160;<span style="font-family: Wingdings"><span id="xdx_90F_edei--EntityEmergingGrowthCompany_c20250501__20250501_zu0aZjyqx524"><ix:nonNumeric contextRef="AsOf2025-05-01" format="ixt:booleanfalse" id="Fact000025" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section&#160;12(b)&#160;of
the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 29%; padding-right: 1.5pt; padding-left: 1.5pt; text-align: center"><span style="font-size: 10pt">Title
    of Each Class</span></td>
    <td style="vertical-align: bottom; width: 1%; padding-right: 1.5pt; padding-left: 1.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 29%; padding-right: 1.5pt; padding-left: 1.5pt; text-align: center"><span style="font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="vertical-align: bottom; width: 1%; padding-right: 1.5pt; padding-left: 1.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 40%; padding-right: 1.5pt; padding-left: 1.5pt; text-align: center"><span style="font-size: 10pt">Name
    of Each Exchange on Which Registered</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 1.5pt; padding-left: 1.5pt; text-align: center"><b><span style="font-size: 10pt"><span id="xdx_907_edei--Security12bTitle_c20250501__20250501_zjc5hre1n72"><ix:nonNumeric contextRef="AsOf2025-05-01" id="Fact000026" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span></span></b></td>
    <td style="padding-right: 1.5pt; padding-left: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 1.5pt; padding-left: 1.5pt; text-align: center"><b><span style="font-size: 10pt"><span id="xdx_90C_edei--TradingSymbol_c20250501__20250501_zBUxCorJeXR"><ix:nonNumeric contextRef="AsOf2025-05-01" id="Fact000027" name="dei:TradingSymbol">ARMP</ix:nonNumeric></span></span></b></td>
    <td style="padding-right: 1.5pt; padding-left: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 1.5pt; padding-left: 1.5pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90E_edei--SecurityExchangeName_c20250501__20250501_za6ceZvXTmEc"><ix:nonNumeric contextRef="AsOf2025-05-01" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">NYSE American</ix:nonNumeric></span></b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 10%; font-size: 10pt"><b>Item 8.01</b></td>
    <td style="width: 90%; font-size: 10pt"><b>Other Events.</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On May&#160;1, 2025, the Company issued a press release announcing
that it had received $4.65 million of additional non-dilutive award funding from the U.S. Department of Defense for the development of
bacteriophage therapy to treat&#160;<i>Staphylococcus aureus</i>&#160;bacteremia infections. The full text of the press release issued
in connection with this announcement is attached as Exhibit&#160;99.1 to this Current Report on Form&#160;8-K and incorporated herein
by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 10%"><b>Item 9.01</b></td>
    <td style="font-size: 10pt; text-align: justify; width: 90%"><b>Financial Statements and Exhibits.</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 5%">&#160;</td>
    <td style="font-size: 10pt; width: 10%"><b>(d)</b></td>
    <td style="font-size: 10pt; text-align: justify; width: 85%"><b>Exhibits.</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center; width: 12%"><b>Exhibit<br/>
No.</b></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 86%"><b>Description</b></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top; text-align: center"><a href="tm2513778d1_ex99-1.htm">99.1</a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="tm2513778d1_ex99-1.htm">Press Release, dated May&#160;1, 2025.</a></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top; text-align: center">104</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: justify">Cover Page Interactive Data File (embedded within the Inline XBRL document</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td>Date: May&#160;1, 2025</td>
    <td colspan="2"><b>Armata Pharmaceuticals,&#160;Inc.</b></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 5%">By:</td>
    <td style="border-bottom: black 1pt solid; width: 45%">/s/ David House</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="white-space: nowrap">Name:</td>
    <td>David House</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Title:</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Senior Vice President, Finance and</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Principal Financial Officer</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>


<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2OkzXovAysYgsQiK6XXKMJd2R2e3vkXrLNiUaBobhnO8cIUZiRUvdIMNpURZwwLZrlEMosUZGc0bvyNabFPwt8aKtY2Vc//7AjDyDnpmGMlFe6K13bbFKIZqPZTKWE4hkOpnBfiuCr56RqXWFxmnVgDIV7Jk61ugUv4aEg3qSofbVVx2RrSaTQhxGg/wGGcUSdnRXD+KrhaLIRDDqJxArplvnXfnTofmSkDfY+jo70P8NPgqFSpM= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2513778d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="tm2513778d1_99-1img001.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Armata Pharmaceuticals Receives $4.65 Million
of Additional Non-Dilutive Award Funding from the U.S. Department of Defense to Support Ongoing diSArm Clinical Trial of AP-SA02</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Phase 1b/2a diSArm trial evaluated AP-SA02 as
a potential treatment for complicated Staphylococcus aureus bacteremia</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Topline data anticipated in Q2 2025 to support
potential future pivotal bacteremia efficacy trial</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">LOS
ANGELES, Calif., May&nbsp;01, 2025 -- Armata Pharmaceuticals,&nbsp;Inc. </FONT>(NYSE American: ARMP) (&ldquo;Armata&rdquo; or the &ldquo;Company&rdquo;),
a biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant
and difficult-to-treat bacterial infections, today announced that it has received an additional $4.65 million of non-dilutive funding
pursuant to a previously announced Department of Defense (DoD) award, received through the Medical Technology Enterprise Consortium (MTEC)
and managed by the Naval Medical Research Command (NMRC) &ndash; Naval Advanced Medical Development (NAMD) with funding from the Defense
Health Agency and Joint Warfighter Medical Research Program. The award, currently totaling $26.2 million, was awarded to Armata to support
clinical development of its optimized phage candidate, AP-SA02, as a potential treatment for complicated <I>Staphylococcus aureus</I>
bacteremia (SAB). The additional $4.65 million will be used to support Phase 2a study close out activities as well as for the preparation
and execution of an end-of-phase 2 meeting with the U.S. Food and Drug Administration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;The DoD has been an essential partner throughout
the development of AP-SA02, and we are very grateful for their continued support of this important program,&rdquo; stated Dr.&nbsp;Deborah
Birx, Chief Executive Officer of Armata. &ldquo;We remain committed to efficiently advance AP-SA02 through full clinical development and
introduce this novel phage-based anti-infective for the benefit of military personnel and civilians alike.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;At Armata, we remain laser focused on demonstrating,
in rigorously designed placebo-controlled clinical trials, the potential of phage therapy to successfully combat evolving deadly bacteria,
including systemic <I>Staphylococcus aureus</I> infections. In parallel, we have developed our proprietary manufacturing process with
complete in-house U.S.-based capacity to support clinical development as well as full future commercial production. This not only allows
us to be efficient but is also expected to ensure immediate access to patients in need if AP-SA02 is found to be effective,&rdquo; Dr.&nbsp;Birx
concluded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The diSArm study is a Phase 1b/2a, randomized,
double-blind, placebo-controlled, multiple ascending dose escalation study of the safety, tolerability, and efficacy of intravenous AP-SA02
as an adjunct to best available antibiotic therapy compared to best available antibiotic therapy alone for the treatment of adults with
SAB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This study was conducted in two phases: Phase&nbsp;1b&nbsp;evaluated
the safety and tolerability of multiple ascending intravenous doses of AP-SA02 or placebo as an adjunct to best available therapy (BAT)
compared to BAT alone in subjects with SAB. Phase 2a evaluated the efficacy, safety, and tolerability of multiple doses of AP-SA02 or
placebo as an adjunct to BAT compared to BAT alone in subjects with complicated SAB. The study achieved full enrollment of 50 subjects
in November&nbsp;2024, with the last patient visit having taken place in January&nbsp;2025. During the execution of the trial, Armata
was able to dose escalate to 5e10 PFU every six hours (2E11 PFU every 24 hours) for five days without clinically significant adverse events.
In parallel with dose escalation, the evolution of two distinct blinded subsets of subjects receiving phage has been observed. One subset,
comprising approximately half of the treated group, has evidence of persistence of detectable phage in the blood consistent with <I>in
vivo</I> phage amplification. This suggests that, despite the best available antibiotic treatment for greater than five days, reservoirs
of active SAB remained that Armata&rsquo;s phages targeted, infected and killed before recirculating in the intravascular space.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2513778d1_99-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of now, the Company anticipates receipt of
topline data in the next few weeks, where it can explore the two aforementioned subsets in an unblinded manner. Topline results are also
expected to inform the optimal dose of AP-SA02 to be evaluated in the larger definitive efficacy study.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
more information on the diSArm study, see&nbsp;</FONT><B><U>NCT05184764</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, Armata filed its Annual Report for
the year ended December&nbsp;31, 2024 on Form&nbsp;10-K with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on March&nbsp;21,
2025. The audit opinion included in the Company&rsquo;s Form&nbsp;10-K for the year ended December&nbsp;31, 2024 contains a going concern
explanatory paragraph. This announcement is made pursuant to the disclosure requirements of NYSE American Company Guide Sections 401(h)&nbsp;and
610(b)&nbsp;and does not represent any change or amendment to the Company&rsquo;s financial statements or to its Annual Report on Form&nbsp;10-K
for the year ended December&nbsp;31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Armata Pharmaceuticals,&nbsp;Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Armata is a clinical-stage biotechnology company
focused on the development of high-purity pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat
bacterial infections using its proprietary bacteriophage-based technology. Armata is developing and advancing a broad pipeline of natural
and synthetic phage candidates, including clinical candidates for <I>Pseudomonas aeruginosa, Staphylococcus aureus</I>, and other pathogens.
Armata is committed to advancing phage therapy with drug development expertise that spans bench to clinic including in-house phage-specific
cGMP manufacturing to support full commercialization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2513778d1_99-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This communication contains &ldquo;forward-looking&rdquo;
statements as defined by the Private Securities Litigation Reform Act of 1995. These statements relate to future events, results or to
Armata&rsquo;s future financial performance and involve known and unknown risks, uncertainties and other factors which may cause Armata&rsquo;s
actual results, performance or events to be materially different from any future results, performance or events expressed or implied by
the forward-looking statements. In some cases, you can identify these statements by terms such as &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo;
 &ldquo;could,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;may,&rdquo; &ldquo;plan,&rdquo; &ldquo;potential,&rdquo;
 &ldquo;predict,&rdquo; &ldquo;project,&rdquo; &ldquo;should,&rdquo; &ldquo;will,&rdquo; &ldquo;would&rdquo; or the negative of those terms,
and similar expressions. These forward-looking statements reflect management&rsquo;s beliefs and views with respect to future events and
are based on estimates and assumptions as of the date of this communication and are subject to risks and uncertainties including risks
related to Armata&rsquo;s development of bacteriophage-based therapies; ability to staff and maintain its production facilities under
fully compliant current Good Manufacturing Practices; ability to meet anticipated milestones in the development and testing of the relevant
product; ability to be a leader in the development of phage-based therapeutics; ability to achieve its vision, including improvements
through engineering and success of clinical trials; ability to successfully complete preclinical and clinical development of, and obtain
regulatory approval of its product candidates and commercialize any approved products on its expected timeframes or at all; and Armata&rsquo;s
estimates regarding anticipated operating losses, capital requirements and needs for additional funds. Additional risks and uncertainties
relating to Armata and its business can be found under the caption &ldquo;Risk Factors&rdquo; and elsewhere in Armata&rsquo;s filings
and reports with the SEC, including in Armata&rsquo;s Annual Report on Form&nbsp;10-K, filed with the SEC on March&nbsp;21, 2025, and
in its subsequent filings with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Armata expressly disclaims any obligation or undertaking
to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Armata&rsquo;s
expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Media Contacts:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>At Armata:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pierre Kyme</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Armata Pharmaceuticals,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ir@armatapharma.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">310-665-2928 x234</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Joyce Allaire</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">LifeSci Advisors, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">jallaire@lifesciadvisors.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">212-915-2569</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>armp-20250501.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaCGubOdzZR+qYkxtmBwbYlqTy8mLL+KICqinxN20fcA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:armp="http://armatapharma.com/20250501" elementFormDefault="qualified" targetNamespace="http://armatapharma.com/20250501">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://armatapharma.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="armp-20250501_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="armp-20250501_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>armp-20250501_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>armp-20250501_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://armatapharma.com/role/Cover" xlink:href="armp-20250501.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://armatapharma.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2513778d1_99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2513778d1_99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !_ +\# 2(  A$! Q$!_\0
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MDPZE>K96FJ+H=YI^I)IEA>0RZS;27^G"W98$MI)Y)'_/SQ=^Q#\*KGPCX_\
M@-%X?^+VK^$/$_CB?]HK4_$,WB_3DU"[\;KH=^]GX0MX4\/7\1T&ZTJ]GT&[
MU%XVU=-4<7\<MY<VT<E?7\+T<I]LZV8U*D*3?+6E#+:&*</;WPV)KT*L>(<
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MJ#G'IVK^(G]I&YN1^T7\?0+N[ 7XR?$XJ!<W"@+'XTU@8&) JJHP !PH 50
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MJ_UR_NK_ $[^TY+"TLH&N;A[6U>TN+B2ZD2';!;VL3375SY,"!I'05Y9X?\
MCU=ZMX@\,^%O%'PF^(OPW7QR;F'P5K?BW_A!Y]-U6_L=&O?$,FC7Z>%_%?B*
M]\-ZU+H.GZAJUCINMZ;9S75M8W\*,NH6EQ8Q^'Q/XGXW/.$>%^!L=4I8=Y'"
M4JU95*DIYDJ,:V'RZI6E"A4C2I8;#U84*%2HVL0XU9PBK6C[O!G@I1R'C+C#
MQ&RVE3Q$,V594,+*IA:<LIGS?VEG='#PK9CAY8_$UI1J8JMA<JAF.+H4XQC.
MCRJ[_E0_;7\,Q>"OVMOV@=!55AA;XDZSK=J@P!]C\5&+Q-"RGY@P:36)\MS@
M_*<8Q6?\>/VB-2^,OA+]GSP=+<R#2O@E\'M%\#11RLXCF\1PSNFIZFF77SD.
MEZ;X;L0TF!(VFMA1'(0W]6?CWXDV.@>/+7P7IWP6U?XJ>(]0\)/XUO;G11\+
M;06.BQ:T/#L N[SX@^+O#$TL\]X$6"WLEOW%N"P6/RV0[>H^+/#GAWX6^*/B
MCXR^#_\ PAL/A+0=>\1ZKX5U#3?AQJWB 6&@V]Q<L(+KPMK7B#P]+/J%O;-)
M8P+JYG4$)>16SC8?TW+OI#Y/3H9#A\;PK6Q68\%82>$CCJF:1I8>EB?[(P^5
M8VHI5,I]E43H591<:.)Q').SG.,I1YORG,_HK\2M9OB\OXQPF5Y5Q_C*.*67
M5LMP6+S'%4*^>8_.L!*&!I\74,RI498FA6A1K5,LI0K1PDYQ3A>"_$#_ ()Y
M_P#!/'X9?M(_"/7/BI\81XP@M[SQ=J&B^";?PUKL6B++I6AQQ6^IZA<E]/NV
MNO-UA[FTMY&=4\NQ8[6+Y7[X?_@CO^R&J,%D^+7*E06\<PNJDC ;RVT%@XZ#
M& <#&02*_0;Q1XRT#X9^";7Q%/IKQ:/<ZWX(T2WT_2[6TMGAN?'_ (LT/PK8
MRBWMVAM%6#4/$-M=7[H0Q@BN)LNP!;EOBW\7=:^$^C:CXD'PO\;>./#NBZ/K
M&NZ_JOA;4? -I!H>G:':&_NGOX/%WCKPYJ-W)+9Q7,MM'HUCJ63;-'.T$DL(
M?\UX@\:N+\9FV<YKA.*<]R;!XC$1QU/*\NQ&,GA\'AL;[2IA:<*6 P]6K54H
M4YJ4EAYIM2;45)W_ $_A3P X*P>4Y)DV(X/R'B#,IPG@)YQF.'P$,3F68X=1
M6-J2Q.99A@Z,)0J5J3C'VZY7.#6MF_XPOB!X5UWX4?$GQ?X%U:=K'Q/\._&&
MJZ#/>(7AFBU/P]JLT-OJEK(%4[I_LUMJEE<A0C+<07$+LK,4_<G]NCXS6GQZ
M_P"":/P<^* N(9+[Q#\0O  \10PLF;/Q9I&B^--+\4VDJJ0D>S6K.YDC);)A
MFB< HZ[OU\\"ZL/B##?:OXD^#%[X"ED-G-;'QI#\-]:NM;CO+;S?M-O<>$/$
MOBHQ1P*D2RKJTEI<A98V2 J&5:&@_$7X;Z[\&K?XM3:-8:'\.V\-:IXVGM=7
MT6R2"PL-)%Z]_=WFF6,%];#4%6UGE40QR3RHZ+&6DDDB3[+.?'3 \09AP'G6
M(X;J4<RX.S##9S/%5LQI8:GFF#H8+#4\PC.C4P,:V%H8BLZ%90KPO3E"R4DY
M2?P^3_1SS?A?#>(N0X;B:=7+^,,!+AN6$P^!^NSRS%8G$5Z^7588G#9K6PV)
MQ&&I2KT.>E5491E.3E&R4?YOO^"2<D;_ +:7A@+(F\_#WXCA0'.23IEBRKM&
M6Y$<A& 1\IVY.0/'OV^OC;!\<_VI/B-XCLK^*Y\,^&-1B^'7@THY:)=!\(3W
MEE-=6[*?FMM8\22:]K"RL5=DO(,HB>66_IJ\+_%[1KGQ/X4T?6_@OXQ^$MQX
M]^TV_@;7/$FB^ ;6TUR]MM&N/$]WH5R?"'B37M9\+:S)X=TO4]3ATWQ-;Z2]
MU#INHV:@ZE"MA-W_ ,7_ !3\+O@K\/?$/Q*\8^%]*DT'0SIXOXM.\-Z7>ZK<
MG5-3L='LTL[,01FYD-W?1&2.-@PMTFFVLL9SK#QVRO\ UVS'Q"K<-5JM2AD&
M R*A1K9C2YL'3H5?K&*Q,H?4;UZ6,P&,P\*$X*FXQG*JW./NLK?1EXGCP7E7
MA:N)US8SBC%9[4J8/+*.-GG&(QT%EV5Y?@Z]+-\QP\L7@L?0S*GB(4J]1.=2
MG&4(2HJ_X[?L6?\ !,+X*_&/]GCP+\4OC&WCR#Q;XZCU+7=/M-!\1PZ'86OA
M22_EA\,$VSZ5<-+<:AID<>J_:0\0DAU"!/)0HSR?1OC3_@CO^S2?"?B;_A"K
MSXF6?B\Z!K(\,7&H^,X+RPAU]M.NAI$EY;#1XC<6@U VXNH1+'YD9PS_ ':_
M5"+4-/T_26U&WCMO[*LM&>]M_P"SRC6PTZUMWE@73UC\FU%M]FAS L8B39Y>
M"%(84O!_B_3O'?@7PMXYTR.>TTSQAX7T'Q7ID-TNV\@L_$.DV>L6L%W&&D6.
MZA@O(HKE%D=8YE==Q45\7B_&#CK$9S7QF%XKSG"RQN)JYS@\KP^.G1PM'"UL
M92HTL/&$*=G2E6G2P\W*]U.;246T?:X/P3\/<'P[A<)C>#LGQE3!X6GD^,SJ
MOD^'6*JX^C@ZE:OB93YGRXJ5.$L3)Q2YJD(6LXV/X<_!7C'Q%\+?B#X4\<Z,
MLFF^+_A[XOTGQ%9:?,S0M#K?AW5H[AM*U&$, !<2VKVE];2GB*::VN8O)N)X
MF_N,^''C;1/B3X#\'_$'PU<+<^'_ !MX;T?Q5H\J,IS8:[80ZA;QN$RJS013
MI#-$</%*C(X#@@>'^-_B!X7\.^*[KP9X=^$>H?%'Q/;Z-!XH\1:?X6T7X?V:
M^'M%U.ZU2#2[O4=7\;^(/">ESZGX@N-,U%-%T:QO;_5KV/2-7NY+:WM[>.2;
MV[X:^)O#WC#P1H'B3PK:SV.@ZI:,UA876EW&A7>G"VGEM+K3+[1+JWM;K2-0
MTR^M[G3[_3IX(Y;.]MKBWD&Z,UU^)/BEE/B7B,MY<I>7YSDU&KA<166,I8J-
M3#?5\-2Q6$@H87#2A2PV/C5K4+\_LZ>)=&5Y1=1\?A9X,YWX34,U=?.HYEDF
M?5HXNAA9X=82KA\1/$XBO@,<L.\?BZ\8YAE<X?O,12POUV.%^N4(NE=1\\_:
M6W#]GC]H38!N7X)_%8H,9&X?#_7]HP 202>@'X&OGR"R^)WQ4\(_"#PM)\,+
MGX?>%M&UCX->._$OC+Q%XL\$ZO<7VG_#F_\ #/C?3[7P]H?A35M?NYK[7M=T
M/2[*:ZU<:5#9Z7/J-R%F+0Z;<_77Q0\)Q_$#X;_$'P(NH#2O^$U\$>+_  B=
M4:W^U_V;_P ))X?U31&U VOF0BZ%DM[)<M;>;!YXB$7G1!MU7_#&BQZ'H6C:
M*X2?^Q=#TS1VE,$:&\_LZPCT^-I8\%HS<00B18S)(B*[0K\B*#^/8K+JU;,E
M4G6JTL%_95/#XFC3IX=QQO+FN'K_ %2M*O";5"<924XT[.3E=R[_ -%Y?Q-A
M\IX:HX2AAL'7SN'%>.S'"5L0\5*KEU"OPC0RN./PM.A6I8;$U88J&(B\/F$*
M^$FU"4Z4N2+/EOXE-X[M?VG_ (8R?#_3_!]]JJ_ 'XTK=)XOUC6=&L$L)/B5
M\"RTT,^@^'M:FEN?M(MBB2P0VD<,MRTLI"KY=KX$/XOD^.'[3$OCG3_"^G^(
M%M/@7OM/"6KZEK6BI:IX5\2BS*:CJ^B>'[^>Y8!TN(GT^.*,JGE$B1L^X7_P
M[^V_%GP[\46U39+H'PZ\8> %T;[.&CFC\7>(_!'B%]7-[YZ^6]B/!_V-;(VL
MJS_V@;E;BU>&1+B+PM\/1X>^(7Q-\?'43=#X@VO@. Z8+1HX]''@G2=5TY9!
M=)//]L?46U229=T%J;6&WB@!F 5DRIX"I_:"QCK8N<WG%;&*DJL%0=/%9;AZ
M$8\CIO2S<KN6\7HFVS.>>8.ID\\ J&6^V_U5P&60Q4</6_M&..P^=?7JD'BZ
MF-Q$JGL\/5JRM4IQ:C0:3O+FC\1?$_Q=X5UC4/VDOB<OBKP;!XO^$?BGX=Z7
M\.]-O?$FCVVJO'^SY=Q?$3Q;:6-G/<K=-+XHU7Q+XM\$7D,2/+J5O8"&-#+$
MC#W[]I+5+F]\#_"SQ'X0L]/UJYU#XZ_ *_T"TO-5;1[#5TN_&VC7UBESJ\6G
M:N;.">*1'%U#IFIKY,<<JVTRD,O6^ ?V?/ 7A#P=HWAC7_#GA#QOK"'6+_Q1
MXLU7PEHG]H^(_$GB;4]4USQ'J[)>VFI75N;W4-5U#R+<ZG=-8VLL=L;B81JQ
MPX/@U)HOPJ^$_P .!XHDOS\)?%'P^UBPU*2P59-6TWX<^(H+K0=%NX8[^18;
MN71H[#2+B]$DT1N[?[8EDI8PCQ99?F,\+C(7HQGG&#PTZRH-4:L,REG=+$.-
M?GYU]:E@?9X:I4LH5'EU248QIU(4X?1KB+AN.8917IU,=*CPQFF)6%^M85RI
MXC(WP?C\"WA%A*+<*<\^R^AF5/#5FZTJ^<XFT[PJ\W(> I?%WQ/^.^J^(/B)
MH'AOP3=? ?2=7\*Z5X0TGQ%=^++K4[SXJ:-X7UY?&T^LS>'_  O!'X>3P]HK
MZ!HEM#87$ESK,7B2:^NH)],6(^5>+KRV^'_[0OQE^.<]Q;Z?IOP^\5?"70?B
M#>R;?LD7PR\>_#'3=)US4-04*\DEGX9\36'@_P 3SS(#)9:9I6JR$&-Y&'VB
M_P -E'Q=L_BCI^JBU6?P!/X%\5:"UD9$U\V6M0:UX5U9[H3QO:W?AE[OQ78P
M*T,Z7ECXKO58H]M :HZ7\)]'MO$WQFUW6S9>(]'^,4GA>WU;PUJ^CV]SI5KI
MFA^%(O"<^FW27C7-IJ]KJ\*275Q')80P1B5K9X9Q^_D[Y97C:E"%%XBK];PV
M:5JZQ\U'VM:$J%6C2QGL::CAZ*Y:K4J5&,>>,6I3]Y6\[#\29=1QKJ^QBLJG
MPIE?#SRC!.<*L:%;'T:V?9;3G4=5JK6K5LVX@HUJGM(4LXKX>M.BZ6#5*?S)
M\ M/N4^-+>.?$5FUAXA^*/P6UKXFZXLRA+BQMO$GQ'TU?"FA74; W$,WAKP;
MI?AOP_<VLLA,%[IMVSI'/<3%H/C,?#?Q/^)_Q:\(:GXF\.Z#<_#3X*#P[X3F
MU;7-*TR6R^)_Q)E'C&+6K>WO;NWDDNM#M/"'P]>SN439#'K,PBGWO<*GU9%\
M/MGQ./Q#2\$2M\/6\"_V)Y$9A\L^*H_$1U,7)<!WCAB-G]F^S*JAQ*2<;6Y;
MPK\"/!6EW7C34_&7A_PGX[\2>,_B#XB\:WVO:]X3T:_NK>/5OL]IH6C0-J$.
MH3QV/AOP[I.D:)$8KA(Y1IXNS!%--*#I_9.(I8:6 P]'"UH5\TS7&8F->4W&
M4FJ.,H5YR3?+6KYC"KBZS:]G*\80C'DM+IJ<7Y=5S27$%2IB,/C*/#&1Y?EF
M#RZA0A5PF-_M/,J>(PV&ECX3P_U7)<@RO#Y9&FYTY58XNI.,90J5H2\F^+'C
MZU^)W['_ /PL.RAB%IX[\,?#779(HY8Y(8I]4\4^$6U33P=[(R6,KWMJX+,%
M:&16;[N[[#GL;*>XADNK.UNEL;Q[NQ:>V6:2SO5CGB%S;&5)!!<1VTLT4-U%
MY$JV\GV<3K'N63P33?@7867PF\>?!6[U$GPEXHU?Q_=:&VF01:7?^#M*\::]
M>>([#2M*.^XMS+X4U74)[G1;CRX;=(H+.V-M'#!@YND?#7XNW_B?P9JGQ-^(
MN@>(--^'UU<ZWI&G>$?!NK^&+CQ3X@&A7WAVTUGQI<WWC'Q/:A-.T_4M0GM]
M T&WLM-N]>F@UBXGDATRRTQ-J5/'4*L)U<,JTZN397@Y*E.*IK%8'&XZ5:2Y
MKRA0KJI%T*CYE.,6TERM'FXZKD>)RS%X++\UP^7X3*.).)LUP5*LL8L=BLMS
MC!9>L!1PT:&"KT,3C,)BL#/+\=3JX[+/JM!U,RG5K8.G6HRYCQY>?$*T_:9M
M'^'GAOP?XBNI?@!)_:$/B_Q3J7A>UM[<_$DXDM9-+\(^)Y;FYE+S+<))%9Q6
MY)=;HRQK W2_'_\ MR7]DSXV?\)'IVD:;K4GP6\>M?V.A:E>:SI%I>+X9U82
MV]CJFH:7HMU?1K&J_P"DS:59/YK2)Y96-#6[XO\ AU\1[CXDVOQ&\!^*O!F@
MW9\ 3>!;W3/&'@O6O$\9">)I?$EMJ&G3Z-XY\*O;RB0O;W*SM?6\X164Q,I$
MO5ZEX.UOQE\,]?\ !'Q1O-&U.3Q5I&O>'-<N/!ND:EX:L;C1=;M+C39;6"RU
M;7/$U[;7GV*ZD1I9=5G0N \:1*/+,8:E6A4XAI^TQ,(XO%YG7H_6*M!Y<H-Y
M=0BX3C.HZ?/[)M<SBI*:2UBVZK9I@H_ZC9A%Y0WD6&X8IXNC3HYB\]6(P.8X
MBIBU.@Y5L)7I8?EC"%3#9A1C/V[M2F_=?GW[1,N?@9HP$;Y_X6#^SNQ8#C/_
M  N_X<;0I.-Y;B, '(X&,"NK_:7W+^S_ /'>3( 3X-_%(,F.68>#=7*MD?*-
MA4G(&0#P<UYN_P &_B]XE7PAX9^)'Q*\,>(_!'@O6_"WB"YBT'P=JFA>,_&]
MYX*O;;5?"47B75+SQ5K>AZ3:Q:]I^E:SXCA\/:/')K]WIB16]QHUM/)"OT!\
M4/!Y^(?PP\>>!HKX:9+XV\%>*/"J:BT0N!8/X@TBXTC[:T&Z+SQ:"Y,[V[R1
MB7#1,1NW+G5PE>MA<YG##5:,Z^4_4(4ZZA[9U\%EV84)2@J%><E2G+%Q=&HW
M'VGLY2BMG$CF& RO'\)4/KN&S"GE'$]3B/&8G /%/!3R^OQ#P_C:$56QF R^
M<<3_ &?DE7$XO"3PTYX)8RC0Q%6O4YV][PJ!_8&BN0&']DZ:2A'!Q;PLO)[@
M$ ')QC%? L(+_P#!.;3%.%2Y^&VGQ2;N%>.^\6QP30S-R3%);W$RR94A@S%C
MR0?T*TNW33M+MM/)$S6%C:V;OM*J_DV\<6\*7<A6( V"1MJ;5#C@GP#0_@G8
MV?[/L/P#UK59]1L7\$ZGX)O-:TZ*+3=04WAO'CU:R60W:6EYIL]S;WVG,SR+
M%=VZ/)N5]J]>)PN(Q,94Z=&,ZG]B8S"1C6?[J57$83 4Z%*I/HVE.=W?FC&5
MK,XLCSC+\HQV#QF*DJM'"\9</9Q4I*$YSJ8#+LQQN(J586YDHS48T[.$_>G%
MN,XQ=.7N,^GZ?<S0FZT^SNSI]\;K3)+BWMYY;"[BAGMUO;*6X5VMKU;>XNH8
MKBW:*<6DLJ>;B4J?G?XQW_A[Q9\6?@M\+]>FTT:%:P>,/BYXMM-4N[>WLM5T
MOPMIH\%^'=%NHIYD6Z@U#Q/X[_MF"#RYX9IO"I9A^[20.TGX;_&'7=?\#ZC\
M3?B%X7U;0_A]?SZU;V/@CPIK/A?4/&GB-O#^IZ!9:CXL-[XM\0V%IIFFKJUS
MJB>'=$A2SN==M]+U&2ZA@TV"PK8D^ OA37OB5XX^(7C[0?"GQ ;Q'HG@[P]X
M7TKQ1X:TS6;?P?HWA6#Q!>3Q6*ZO%J"&YUO7_$VJWUW/:Q63O;Q:?:.SI;Y!
M7A6QN'=*&$I4DL?E^%Q'UCW*53!8;#47B:ZL_>HO$1>'H2YK5%1E43]G:*6
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M83\(=4TY]+^.5Y=6OQ8^ [1^-Y='_:1TCQ;XGT--0L9_B+J>M?#*?Q'<^/\
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,$\T*CE[:C*/+/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 01, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  01,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ARMATA PHARMACEUTICALS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000921114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">91-1549568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">WA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5005 McConnell Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">655-2928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ARMP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( .TXH5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( .TXH5H8?LX[[@   "L"   1
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MM5II ,,X?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A
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M              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @
M[3BA6AA^SCON    *P(  !$              ( !PP   &1O8U!R;W!S+V-O
M<F4N>&UL4$L! A0#%     @ [3BA6IE<G",0!@  G"<  !,
M ( !X $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #M.*%:015C
M<$($  !N$   &               @($A"   >&PO=V]R:W-H965T<R]S:&5E
M=#$N>&UL4$L! A0#%     @ [3BA6I^@&_"Q @  X@P   T
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;72YX;6Q02P4&      D "0 ^ @  [1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2513778d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://armatapharma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>armp-20250501.xsd</File>
    <File>armp-20250501_lab.xml</File>
    <File>armp-20250501_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2513778d1_8k.htm">tm2513778d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2513778d1_8k.htm": {
   "nsprefix": "armp",
   "nsuri": "http://armatapharma.com/20250501",
   "dts": {
    "schema": {
     "local": [
      "armp-20250501.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "armp-20250501_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "armp-20250501_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2513778d1_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://armatapharma.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-05-01",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2513778d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-05-01",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2513778d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001104659-25-043017-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-043017-xbrl.zip
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M$75@"1%2/IF1DW(A!"1I,R4""+ZG!L;X53C'R:P4P%E:G.A,L;E'[1G'5;;
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M^N@N?YB6MG.]_.,KA)&VT[!/CKE*/AHNOK;SO;BSVIOPCK6BI)=W08-WO+N
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M&J>@0MZ#F/$^2+2?D!20'.I)]GKBS"<(5EF;VOH@ 8IW0M+=W."2@:UE%F"
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M:)$RZ7R5UUQKN;%Z1@W;%@&_Q,?$+_%9<4TYC#C)]@\./*UVJLWTK*I:ON'
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M]>UC<H=P $$LLKXRLP@N/,BJZ@2$5N2H"W'8#KR&R_$;FQL>$%JWR.IM+=4
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MH']>-W*'_L39_\TS_6GT_P-02P$"% ,4    " #M.*%:$(:67"L#  #N"P
M$0              @ $     87)M<"TR,#(U,#4P,2YX<V102P$"% ,4
M" #M.*%:)"[-C/P*  !_A@  %0              @ %: P  87)M<"TR,#(U
M,#4P,5]L86(N>&UL4$L! A0#%     @ [3BA6L;HXX%8!P  W%<  !4
M         ( !B0X  &%R;7 M,C R-3 U,#%?<')E+GAM;%!+ 0(4 Q0    (
M .TXH5JS4Y/-1Q(  "9@   2              "  106  !T;3(U,3,W-SAD
M,5\X:RYH=&U02P$"% ,4    " #M.*%:J*&K-<T0   A/0  %@
M    @ &+*   =&TR-3$S-S<X9#%?97@Y.2TQ+FAT;5!+!08     !0 % $D!
(  ",.0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>tm2513778d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="armp-20250501.xsd" xlink:type="simple"/>
    <context id="AsOf2025-05-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000921114</identifier>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-05-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-05-01" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-05-01" id="Fact000004">0000921114</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-05-01" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-05-01" id="Fact000010">2025-05-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-05-01" id="Fact000011">ARMATA PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-05-01" id="Fact000012">WA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-05-01" id="Fact000013">001-37544</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-05-01" id="Fact000014">91-1549568</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-05-01" id="Fact000015">5005 McConnell Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-05-01" id="Fact000016">Los Angeles</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-05-01" id="Fact000017">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-05-01" id="Fact000018">90066</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-05-01" id="Fact000019">310</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-05-01" id="Fact000020">655-2928</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-05-01" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-05-01" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-05-01" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-05-01" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-05-01" id="Fact000025">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="AsOf2025-05-01" id="Fact000026">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-05-01" id="Fact000027">ARMP</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-05-01" id="Fact000028">NYSEAMER</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
